Investors with $13 trillion urge climate approach to superbugs

Antimicrobial resistance, also known as AMR, kills nearly 1.3 million people a year and occurs when germs become resistant to drugs. If left unchecked, it could lead to an estimated $1 trillion in additional healthcare costs by 2050, as well as a 3.8% loss of global gross domestic product and about 10 million deaths annually, according to a report published last month.